(Q46465645)

22 December 2017

title

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial (English)

1 reference

22 December 2017

main subject

phase III clinical trial

0 references

1 reference

1

Andrew Bottomley

1 reference

22 December 2017

4

Fabio Efficace

1 reference

22 December 2017

6

Carolyn Gotay

1 reference

22 December 2017

Corneel Coens

5

Corneel Coens

1 reference

22 December 2017

Patrick Therasse

2

Patrick Therasse

1 reference

22 December 2017

Marzena Wełnicka-Jaśkiewicz

7

Marzena Welnicka-Jaskiewicz

1 reference

22 December 2017

Jaroslaw Dyczka

9

Jaroslaw Dyczka

1 reference

22 December 2017

Michail R Lichinitser

11

Michail R Lichinitser

1 reference

22 December 2017

author name string

Martine Piccart

3

1 reference

22 December 2017

Louis Mauriac

8

1 reference

22 December 2017

Tanja Cufer

10

1 reference

22 December 2017

Jan H Schornagel

12

1 reference

22 December 2017

Herve Bonnefoi

13

1 reference

22 December 2017

Lois Shepherd

14

1 reference

22 December 2017

European Organisation for Research and Treatment of Cancer Breast Cancer Group

15

1 reference

22 December 2017

National Cancer Institute of Canada

16

1 reference

22 December 2017

Swiss Group for Clinical Cancer Research

17

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

Lancet Oncology Commission

published in

1 reference

22 December 2017

volume

6

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

287-294

1 reference

22 December 2017

Global cancer statistics in the year 2000.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Update on locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Age-specific detriments to quality of life among breast cancer patients one year after diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Quality of life in patients undergoing systemic therapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970100-5

7 January 2021

10.1016/S1470-2045(05)70100-5

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15863376

1 reference

22 December 2017